Flavonoid-mediated inhibition of NLRP3 inflammasome activation: Anti-inflammatory insights from Capparis cartilaginea Decne
Planta Medica · 01.03.2026 · 92 (03) · 232
DOI: 10.1055/s-0045-1814950 ↗Kurz gefasst
Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.03.2026. Verfasst von B Govoni und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Inflammation is a vital immune response, with the NLRP3 inflammasome playing a key role in mediating inflammatory activation. Dysregulation of NLRP3 is associated with diseases such as gout and type 2 diabetes, making it a promising therapeutic target. This study investigates the inhibitory potential of flavonoids isolated from the tea of Capparis cartilaginea Decne leaves, a plant widely consumed for its health benefits and cultivated in the Al-Taif region of Saudi Arabia. The identified compounds include quercetin 3-O-(2G-rhamnosylrutinoside) (Manghaslin), quercetin 3-O-neohesperidoside (Q3-Neo), quercetin 3-O-rutinoside (Rutin), kaempferol 3-O-(2G-rhamnosylrutinoside) (Clitorin), kaempferol 3-O-neohesperidoside (K3-Neo), kaempferol 3-O-rutinoside (Nicotiflorin), and isorhamnetin 3-O-rutinoside (Narcissin). In silico analysis, including molecular docking and molecular dynamics (MD) simulations, as well as in vitro assays such as ELISA and Western blotting, were conducted to explore the flavonoids’ potential as NLRP3 inhibitors. Among the tested flavonoids, all demonstrated favourable interaction profiles with the NLRP3 active site, with quercetin derivatives, particularly Q3-Neo and Manghaslin, exhibiting the strongest inhibitory interactions in silico through hydrogen bonding with key amino acid residues. Other flavonoids, including Narcissin and Nicotiflorin, also exhibited significant inhibitory potential, while Clitorin and K3-Neo displayed weaker binding dynamics. The interactions between the hydroxyl groups of the ligands and the carboxylate side chains of Glu629 and Arg578, observed in this study, align with previous findings. These computational findings were corroborated by in vitro assays, which demonstrated significant inhibition of NLRP3 inflammasome activation. These findings pave the way for further investigations into their mechanism of action and potential clinical applications. Publication History Article published online: 05 March 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Zitieren
APA
Govoni, B., Rodrigues, J. C., Alsharif, B., Boylan, F., & Verli, H. (2026). Flavonoid-mediated inhibition of NLRP3 inflammasome activation: Anti-inflammatory insights from Capparis cartilaginea Decne. Planta Medica, 92(03), 232. https://doi.org/10.1055/s-0045-1814950
Vancouver
Govoni B, Rodrigues JC, Alsharif B, Boylan F, Verli H. Flavonoid-mediated inhibition of NLRP3 inflammasome activation: Anti-inflammatory insights from Capparis cartilaginea Decne. Planta Medica. 2026;92(03):232. doi:10.1055/s-0045-1814950
BibTeX
@article{Govoni2026,
author = {Govoni, B and Rodrigues, J C and Alsharif, B and Boylan, F and Verli, H},
title = {Flavonoid-mediated inhibition of NLRP3 inflammasome activation: Anti-inflammatory insights from Capparis cartilaginea Decne},
journal = {Planta Medica},
year = {2026},
volume = {92},
number = {03},
pages = {232},
doi = {10.1055/s-0045-1814950}
}
EUVIMED